573 related articles for article (PubMed ID: 9063247)
21. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy].
Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M
Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792
[TBL] [Abstract][Full Text] [Related]
22. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation.
Han DP; Pulido JS; Mieler WF; Johnson MW
Am J Ophthalmol; 1995 May; 119(5):563-70. PubMed ID: 7733181
[TBL] [Abstract][Full Text] [Related]
23. [Vitrectomy and photocoagulation for treatment of proliferative diabetic retinopathy].
Hui Y; Wang L; Wang Y; Huang W; Han Q
Yan Ke Xue Bao; 2001 Dec; 17(4):241-4. PubMed ID: 12567515
[TBL] [Abstract][Full Text] [Related]
24. Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma.
Bartz-Schmidt KU; Thumann G; Psichias A; Krieglstein GK; Heimann K
Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):969-75. PubMed ID: 10654165
[TBL] [Abstract][Full Text] [Related]
25. Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy.
Hoerle S; Poestgens H; Schmidt J; Kroll P
Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):197-201. PubMed ID: 11935276
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of retinal ablation in proliferative diabetic retinopathy.
Reddy VM; Zamora RL; Olk RJ
Am J Ophthalmol; 1995 Jun; 119(6):760-6. PubMed ID: 7785691
[TBL] [Abstract][Full Text] [Related]
27. Neovascular glaucoma following pars plana vitrectomy for complications of diabetic retinopathy.
Wand M; Madigan JC; Gaudio AR; Sorokanich S
Ophthalmic Surg; 1990 Feb; 21(2):113-8. PubMed ID: 2330190
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment.
Tao Y; Jiang YR; Li XX; Gao L; Jonas JB
Retina; 2010 Mar; 30(3):447-51. PubMed ID: 20216292
[TBL] [Abstract][Full Text] [Related]
29. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
[TBL] [Abstract][Full Text] [Related]
30. An objective analysis of proliferative diabetic retinopathy before and after pars plana vitrectomy.
Federman JL; Boyer D; Lanning R; Breit P
Ophthalmology; 1979 Feb; 86(2):276-82. PubMed ID: 93734
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations of central retinal artery occlusion in eyes of proliferative diabetic retinopathy with previous vitrectomy and panretinal photocoagulation.
Chen SN; Chao CC; Hwang JF; Yang CM
Retina; 2014 Sep; 34(9):1861-6. PubMed ID: 24743637
[TBL] [Abstract][Full Text] [Related]
32. Subretinal hemorrhages in proliferative diabetic retinopathy.
Morse LS; Chapman CB; Eliott D; Benner JD; Blumenkranz MS; McCuen BW
Retina; 1997; 17(2):87-93. PubMed ID: 9143034
[TBL] [Abstract][Full Text] [Related]
33. Oral sodium fluorescein to improve visualization of clear vitreous during vitrectomy for proliferative diabetic retinopathy.
Yao Y; Wang ZJ; Wei SH; Huang YF; Zhang MN
Clin Exp Ophthalmol; 2007 Dec; 35(9):824-7. PubMed ID: 18173410
[TBL] [Abstract][Full Text] [Related]
34. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction.
Lewis H; Abrams GW; Blumenkranz MS; Campo RV
Ophthalmology; 1992 May; 99(5):753-9. PubMed ID: 1594222
[TBL] [Abstract][Full Text] [Related]
35. Re-operation following pars plana vitrectomy for the sequelae of proliferative diabetic retinopathy.
Brown GC; Benson WE; Tasman WS; McNamara JA
Trans Pa Acad Ophthalmol Otolaryngol; 1990; 42():955-8. PubMed ID: 2084993
[TBL] [Abstract][Full Text] [Related]
36. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group.
Arch Ophthalmol; 1995 Sep; 113(9):1144-55. PubMed ID: 7661748
[TBL] [Abstract][Full Text] [Related]
37. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
38. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
Luttrull JK; Musch DC; Spink CA
Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
[TBL] [Abstract][Full Text] [Related]
39. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
Recchia FM; Ruby AJ; Carvalho Recchia CA
Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052
[TBL] [Abstract][Full Text] [Related]
40. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.
Gandorfer A; Messmer EM; Ulbig MW; Kampik A
Retina; 2000; 20(2):126-33. PubMed ID: 10783944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
